Table 2.
Comparison of rs4846048 genotypes and allele frequencies in the control group and experimental group
Group | Cases | rs4846048 (cases) | Allele (frequency) | ||
---|---|---|---|---|---|
AA | AG | A | G | ||
Control | 80 | 66 | 14 | 146 | 14 |
CC | 92 | 55 | 37 | 147 | 37 |
HSIL | 60 | 48 | 12 | 108 | 12 |
LSIL | 45 | 41 | 4 | 86 | 4 |
Overall comparison: χ 2, p | 21.160, .000* | 18.249, .000* | |||
Multiple comparison: χ 2, p | CC versus control | 10.587, .001 | 8.744, .003 | ||
CC versus HSIL | 6.795, .009 | 5.489, .019 | |||
CC versus LSIL | 14.143, .000* | 11.654, .001 | |||
HSIL versus control | 0.142, .707 | 0.127, .721 | |||
HSIL versus LSIL | 2.458, .117 | 2.255, .133 | |||
LSIL versus control | 1.733, .188 | 1.598, .206 |
NCBI Reference Sequence: NC_000001.11 (https://www.ncbi.nlm.nih.gov/nuccore/NC_000001.11?report=fasta&from=11785723&to=11806103&strand=true).
Abbreviations: CC, cervical cancer; HSIL, high‐grade squamous intraepithelial lesion; LSIL, low‐grade squamous intraepithelial lesion.
Means p < .05 compared between groups.